Description
Syncapone (12.5+50+200 mg) contains three active substances, Levodopa, carbidopa, and Entacapone, in one film-coated tablet. It is a prescription treatment for patients with Parkinson’s disease.
Parkinson’s is a neurological disorder that causes slow movement, shaking and muscle stiffness. It is believed to cause due to low dopamine levels in the brain. Levodopa increases the amount of dopamine and hence reduces the symptoms of Parkinson’s disease. Carbidopa and Entacapone help to improve the antiparkinsonian effects of Levodopa.
In patients who have Parkinson’s disease, the brain cells that produce dopamine (a chemical substance used to transmit signals between nerve cells that help to control muscle movement) begin to die, and dopamine level in the brain decreases. The patients then lose their ability to control movement and coordination. All three ingredients-Levodopa, carbidopa and Entacapone, restore the dopamine levels that help to control movements in such patients. All three ingredients in the same tablet can lower the number of tablets the patients have to take and help them adhere to the treatment regimen.


















Reviews
There are no reviews yet.